Prostate Cancer Daily

November 26, 2024

Videos

Peer-to-Peer Clinical Conversations

Epigenetic Profiling Identifies Biomarkers Predicting Resistance to AR-Targeted Therapy in mCRPC - Wilbert Zwart

Wilbert Zwart

Wilbert Zwart joins Neeraj Agarwal to discuss research on epigenetic targeting in prostate cancer.

ARROW Study Reveals Iodine-131 PSMA Efficacy in Advanced Cancer - Evan Yu

Evan Y. Yu

Evan Yu joins Zachary Klaassen to discuss the results of the ARROW trial.

Beyond the Abstracts

Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival - Beyond the Abstract

Testosterone Therapy in Men after Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer - Beyond the Abstract

Prediction of Undetectable Circulating Tumor DNA by Comprehensive Genomic Profiling Assay in Metastatic Prostate Cancer: The SCRUM-Japan MONSTAR SCREEN Project - Beyond the Abstract

Survival of Men with Metastatic Hormone-Sensitive Prostate Cancer and Adrenal-Permissive HSD3B1 Inheritance - Beyond the Abstract

Conference Coverage

ESMO 2024: Targeting Epigenetic Pathways

ESMO 2024: Invited Discussant: RAPSON: Open-Label, Multicenter Randomized Trial of Radium-223 and Adding Metformin to ADT for Patients with mHSPC

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Elucidating acquired PARP inhibitor resistance in advanced prostate cancer.

Discrimination against Gay and Bisexual Patients in Prostate Cancer Treatment: Results from the Restore-2 Study.

Prioritizing precision: detection of prostate cancer using mri guided fusion needle biopsy across the pennsylvania urologic regional collaborative.

French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Management of metastatic disease and castration resistance.

French AFU Cancer Committee Guidelines - Update 2024-2026: Prostate cancer - Diagnosis and management of localised disease.

Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer.

Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes.

A PSMA-targeted Tri-specific Killer Engager enhances NK cell cytotoxicity against prostate cancer.

Racial and Ethnic Differences in Prostate Cancer Epidemiology Across Disease States in the VA.

Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice.

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2024 Digital Science Press, LLC